Nortriptyline Inhibits Lysosomal Exocytosis‐Mediated SASP During Gastric Cancer Progression via Targeting HOXA1‐PITX2 Phase Separation
Open Access
- 25 September 2025
- journal article
- Published by Wiley in Advanced Science
- Vol. 12 (46) , e12407
Abstract
Lysosomal exocytosis, a calcium‐dependent secretory process, facilitates extracellular release of cargos that promote cancer progression, though its regulatory pathways and therapeutic strategies are poorly understood. Herein, using combined transcriptomic and proteomic approaches, we identify homeobox A1 (HOXA1) as a functional partner of paired like homeodomain 2 (PITX2) within biomolecular condensates forming via liquid–liquid phase separation. Mechanistically, HOXA1‐PITX2 complex facilitates the expression of mucolipin 1 (MCOLN1 ) and RAS‐related protein Rab‐3A ( RAB3A ), which drive lysosomal exocytosis of galectin‐1 (LGALS1) and insulin like growth factor binding protein 7 (IGFBP7) from senescent gastric cancer cells. This process potentiates AKT activation and epithelial‐mesenchymal transition, accelerating tumorigenesis and aggressiveness of gastric cancer. Molecular docking and affinity purification assays reveal nortriptyline (Nor) as a potent phase separation disruptor of HOXA1‐PITX2 complex. Preclinical studies demonstrate that Nor administration attenuates lysosomal exocytosis‐mediated senescence‐associated secretory phenotype (SASP) and reduces aggressive phenotypes in gastric cancer models, underscoring the HOXA1 / PITX2 axis as a critical regulator of gastric cancer progression. Clinically, elevated expression of HOXA1 , PITX2 , MCOLN1 , RAB3A , LGALS1 , and IGFBP7 constitutes a prognostic signature correlating with poor outcomes of gastric cancer patients. Collectively, these results indicate that Nor impedes gastric cancer progression by suppressing HOXA1‐PITX2 phase separation and subsequent lysosomal exocytosis‐mediated SASP.Keywords
Funding Information
- National Natural Science Foundation of China (82072801, 82173316, 82473092)
This publication has 67 references indexed in Scilit:
- Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomesClinical and Translational Medicine, 2024
- Therapeutic targeting of CNBP phase separation inhibits ribosome biogenesis and neuroblastoma progression via modulating SWI/SNF complex activityClinical and Translational Medicine, 2023
- HOXA1, a breast cancer oncogeneBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2022
- Therapeutic targeting of SPIB/SPI1‐facilitated interplay of cancer cells and neutrophils inhibits aerobic glycolysis and cancer progressionClinical and Translational Medicine, 2021
- Pitx genes in development and diseaseCellular and Molecular Life Sciences, 2021
- Effects of repeated treatment with monoamine-transporter-inhibitor antidepressants on pain-related depression of intracranial self-stimulation in ratsPsychopharmacology, 2020
- Therapeutic Targeting of MZF1‐AS1/PARP1/E2F1 Axis Inhibits Proline Synthesis and Neuroblastoma ProgressionAdvanced Science, 2019
- Oncogenic PITX2 facilitates tumor cell drug resistance by inverse regulation of hOCT3/SLC22A3 and ABC drug transporters in colon and kidney cancersCancer Letters, 2019
- PONDR-FIT: A meta-predictor of intrinsically disordered amino acidsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- Expression of p16INK4A variants in senescent human fibroblasts independent of protein phosphorylationJournal of Cellular Biochemistry, 2005